Literature DB >> 24614520

CHD2 mutations in Lennox-Gastaut syndrome.

Caroline Lund1, Eylert Brodtkorb2, Ane-Marte Øye3, Oddveig Røsby3, Kaja Kristine Selmer4.   

Abstract

Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy with a heterogeneous etiology. In this study, we aimed to explore the role of CHD2 in LGS, as CHD2 mutations have been described recently in various epileptic encephalopathies. We have previously identified one patient with a large deletion affecting the CHD2 gene in a group of 22 patients with LGS or LGS-like epilepsy. In the remaining 17 patients without known etiology, Sanger sequencing revealed a de novo 1-bp duplication in the CHD2 gene in another patient. This mutation leads to a frameshift and, consequently, a premature stop codon 49bp downstream of the mutation. The patient had prominent myoclonic seizures and photosensitivity, thus, sharing phenotypic features with previously reported patients with CHD2-related epilepsy. In our original material of 22 patients with LGS features, we have now found two (9%) with mutations in the CHD2 gene. Our findings suggest that CHD2 mutations are important in the etiological spectrum of LGS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHD2; Epileptic encephalopathy; Lennox–Gastaut syndrome; Sanger sequencing

Mesh:

Substances:

Year:  2014        PMID: 24614520     DOI: 10.1016/j.yebeh.2014.02.005

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  19 in total

Review 1.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 2.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

3.  Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains.

Authors:  Jessica C Liu; Catarina G Ferreira; Timur Yusufzai
Journal:  J Biol Chem       Date:  2014-11-10       Impact factor: 5.157

Review 4.  Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.

Authors:  Markus von Deimling; Ingo Helbig; Eric D Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

Review 5.  Epigenetic Mistakes in Neurodevelopmental Disorders.

Authors:  Giuseppina Mastrototaro; Mattia Zaghi; Alessandro Sessa
Journal:  J Mol Neurosci       Date:  2017-03-02       Impact factor: 3.444

6.  CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.

Authors:  Rhys H Thomas; Lin Mei Zhang; Gemma L Carvill; John S Archer; Sinéad B Heavin; Simone A Mandelstam; Dana Craiu; Samuel F Berkovic; Deepak S Gill; Heather C Mefford; Ingrid E Scheffer
Journal:  Neurology       Date:  2015-02-11       Impact factor: 9.910

7.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

8.  TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling.

Authors:  Amit Berson; Ashley Sartoris; Raffaella Nativio; Vivianna Van Deerlin; Jon B Toledo; Sílvia Porta; Shichong Liu; Chia-Yu Chung; Benjamin A Garcia; Virginia M-Y Lee; John Q Trojanowski; F Brad Johnson; Shelley L Berger; Nancy M Bonini
Journal:  Curr Biol       Date:  2017-11-16       Impact factor: 10.834

Review 9.  Single-Gene Determinants of Epilepsy Comorbidity.

Authors:  Jeffrey L Noebels
Journal:  Cold Spring Harb Perspect Med       Date:  2015-11-02       Impact factor: 6.915

Review 10.  Nervous system development and disease: A focus on trithorax related proteins and chromatin remodelers.

Authors:  Amanda Moccia; Donna M Martin
Journal:  Mol Cell Neurosci       Date:  2017-11-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.